Consumer and farm groups declared a victory last week in the ongoing ‘milk wars’ when the the Monsanto Company (NYSE: MON) announced that it was "pursuing a divestiture of its dairy product, recombinant bovine somatotropin (rBST), in the upcoming months." This decision by the biotech giant to drop its line of artificial bovine growth hormones, Monsanto’s first biotech product, comes after a nearly five-year decline in use of rBST, which was marketed under the name Posilac.
"What’s happened today could be a great victory for the American consumer," says Andrew Kimbrell, founder and executive director of the Center for Food Safety, a non-profit, that works to
promote organic and other forms
of sustainable agriculture. "Monsanto has recognized that consumers have made a choice to avoid milk made with genetically engineered growth hormones, and that the dairies and markets that serve their needs are not buying milk made with their product. They have clearly judged the time right to get out of the failing artificial growth hormone business."
In 1994, after the U.S. Food and Drug Administration (FDA) approved use of Monsanto’s recombinant bovine growth hormone, the FDA also said that the following label statement, in proper context, is acceptable: "from cows not treated with rBST." Last year, Monsanto unsuccessfully petitioned the FDA and the Federal Trade Commission (FTC) to declare these labels to be misleading.
Subsequent attempts by Monsanto to ban such labeling at the state level have met with strong resistance from local consumers, advocacy groups, farmers and dairies. Earlier this summer, an overwhelming public backlash forced Pennsylvania Governor Rendell to rescind an order from his Dept. of Agriculture to remove labels from milk identifying it as produced without use of rBGH. A similar rule put forward in Ohio is now under legal challenge by groups representing farmers, dairies and consumers (the Center for Food Safety is a co-plaintiff).
"When Monsanto failed to get the federal government to remove "rBST-Free" labels, they went after states like Pennsylvania and Ohio to ban labels, but they’ve been fought every step of the way," said Joseph Mendelson, legal director of the Center for Food Safety. "They have clearly seen and understood that public demand is in favor of transparency and truth when it comes to what’s on our plates."
Scientists and physicians have long raised questions about the long-term safety of consuming milk from cows treated with rBGH, concerns stemming from the milk’s increased levels of insulin-like growth factor, another powerful hormone. Regulators in Japan, Australia, New Zealand, Canada and all 27 nations of the European Union have banned rbGH due to adverse effects on animal health.
Cows injected with the hormone show increased risks for infertility and lameness as well as for udder infections, which are treated with antibiotics. Antibiotic use on animals is a major cause of antibiotic-resistant bacteria, a major public health threat.
Monsanto’s artificial growth hormone business has been in decline since 2002, according to a recent USDA report. The number of dairy cows injected with rBGH dropped from 22.3% of all U.S. cows in 2002 to 17.2% in 2007.
Loading...